Wahid Awad, Ph.D. MBA

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.

What makes Nova different from other networks is the merit-based access. All members need to go through a rigorous selection process to join. Nova is based on the fact that your professional success is determined by your network. Whether finding a business partner, a mentor, or getting peer support, members achieve their professional goals through Nova, one connection at a time. Nova’s platform already connects over 25,000 top-talent individuals living in +80 countries and working in a variety of industries and functions such as sales, marketing, management consulting, investment banking, private equity funds, software, and more. Our goal is to make the world more based on merit. We want to build a society where, regardless of where you are born or what your socioeconomic background is, if you are ambitious, talented, and work hard, you can reach your full potential.

Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and academic laboratories, clinical centres and educational establishments, promoting transfer of innovative technologies; strengthening international competitiveness for the French “health and leading-edge health technology” sector promoting those involved and stimulating the Paris Region’s capacity for innovation; helping to increase the attractiveness of the Paris Region and the vitality of its healthcare sector

Awad & Co is a Management Consulting and Investment firm headquartered in Paris, France and specialized in life sciences, AI for health, medical devices, biotechnology, pharmaceutical, CRO, digital health.

Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock the road to precision medicine by using multiomics, spatial data and AI.

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.

What makes Nova different from other networks is the merit-based access. All members need to go through a rigorous selection process to join. Nova is based on the fact that your professional success is determined by your network. Whether finding a business partner, a mentor, or getting peer support, members achieve their professional goals through Nova, one connection at a time. Nova’s platform already connects over 25,000 top-talent individuals living in +80 countries and working in a variety of industries and functions such as sales, marketing, management consulting, investment banking, private equity funds, software, and more. Our goal is to make the world more based on merit. We want to build a society where, regardless of where you are born or what your socioeconomic background is, if you are ambitious, talented, and work hard, you can reach your full potential.